Is HRT Right for You? A Physician’s Guide to Individualized Care

Hormone replacement therapy can significantly improve symptoms and quality of life for appropriately selected patients. But deciding whether HRT is right for someone is rarely as simple as checking a hormone level or matching a few symptoms to an online list.

Good hormone care begins with a different question:

What is happening medically, and is hormone therapy the most appropriate way to address it?

The answer depends on the hormone being considered, your symptoms, age, medical history, reproductive goals, laboratory findings when appropriate, individual health risks, personal preferences, and how treatment will be monitored over time.

It is also important to recognize that the term hormone replacement therapy, or HRT, covers several very different clinical situations. Menopausal hormone therapy in women is evaluated differently from testosterone replacement therapy in men.

If you are new to this topic, you may want to begin with our Hormone Replacement Therapy: A Complete Guide for Patients.

HRT Is Not One Treatment

One of the most common misconceptions about hormone replacement therapy is that HRT is a standardized treatment.

It is not.

Depending on the clinical situation, hormone therapy may involve:

• Estrogen

• Progesterone or another progestogen

• Testosterone

• Local vaginal estrogen

• A combination of hormones

• Different routes of administration

• Different doses and treatment schedules

A woman seeking treatment for hot flashes during menopause has a very different medical situation from a man being evaluated for testosterone deficiency.

Even two people with similar symptoms may ultimately receive very different recommendations.

That is why the question should not simply be, “Do I need HRT?”

A better question is:

“What treatment, if any, makes sense for my particular situation?”

You can explore the available delivery methods in Types of HRT: Pills, Patches, Gels, Injections, and Pellets.

Hormone Therapy for Women Requires Individualized Assessment

For women, hormone therapy is most commonly discussed in connection with perimenopause and menopause.

Falling estrogen levels may contribute to symptoms such as:

• Hot flashes

• Night sweats

• Sleep disruption

• Vaginal dryness

• Pain with intercourse

• Changes in menstrual patterns

• Certain mood or cognitive complaints

• Changes in sexual health

Menopausal hormone therapy is considered the most effective treatment for bothersome vasomotor symptoms such as hot flashes and night sweats. Systemic hormone therapy can also help prevent bone loss and fractures in appropriate patients.

However, whether treatment is appropriate depends on much more than the presence of symptoms.

A physician may consider:

• Your age

• Whether you are in perimenopause or menopause

• How long it has been since menopause began

• Whether you still have a uterus

• The severity and type of symptoms

• Personal and family cancer history

• Cardiovascular health

• History of blood clots

• Liver health

• Unexplained vaginal bleeding

• Current medications

• Bone health

• Treatment goals and preferences

Current menopause guidance emphasizes individualized decision-making because the balance of potential benefits and risks varies according to the patient's age, timing of treatment, formulation, dose, route of administration, and medical history.

For a more detailed discussion, see HRT for Women: Understanding Menopause and Beyond.

Testosterone Replacement Therapy in Men Is Evaluated Differently

Testosterone replacement therapy, or TRT, should not be prescribed simply because a man feels tired, has gained weight, notices decreased motivation, or has a single testosterone result near the lower end of a laboratory range.

Symptoms associated with testosterone deficiency may include:

• Reduced libido

• Erectile or sexual concerns

• Decreased energy

• Reduced muscle mass or strength

• Changes in body composition

• Depressed mood

• Reduced motivation

• Difficulty concentrating

But these symptoms are not specific to testosterone deficiency.

The Endocrine Society recommends diagnosing male hypogonadism only when a man has compatible symptoms or signs and consistently low testosterone concentrations measured appropriately. The diagnosis should generally be confirmed with repeat early-morning testing, followed by evaluation for the underlying cause when indicated.

This distinction matters because low testosterone can sometimes be associated with other factors, including obesity, certain medications, chronic medical conditions, sleep problems, or disorders involving the testes, pituitary gland, or hypothalamus.

Rather than immediately prescribing testosterone, the evaluation should ask why testosterone is low and whether any reversible contributing factors should be addressed.

Learn more in Low Testosterone in Men: Symptoms, Diagnosis, and Treatment Options.

Symptoms Alone Do Not Tell You Whether You Need HRT

Fatigue, poor sleep, difficulty concentrating, decreased libido, mood changes, weight changes, and reduced exercise performance are commonly described as signs of "hormonal imbalance."

Hormonal changes can certainly contribute to these symptoms.

But so can many other medical and lifestyle factors.

Possible contributors may include:

• Thyroid disorders

• Anemia

• Iron deficiency

• Vitamin deficiencies

• Sleep apnea

• Chronic sleep deprivation

• Depression or anxiety

• Medication side effects

• Insulin resistance or metabolic disease

• Chronic illness

• Excessive alcohol use

• Inadequate calorie or protein intake

• Overtraining or inadequate recovery

• Significant psychological or occupational stress

This is why symptom checklists should be viewed as a reason to consider an evaluation, not as a diagnosis.

Hormone therapy works best when the problem being treated has first been clearly defined.

Seven Factors Physicians Consider Before Recommending HRT

1. What Problem Are We Trying to Treat?

The first question should always be the clinical goal.

For example, treatment may be considered for a woman whose menopause-related hot flashes are disrupting sleep and daily functioning.

A man may undergo evaluation because of persistent sexual symptoms combined with repeatedly low testosterone concentrations.

Another patient may have vaginal or urinary symptoms requiring local rather than systemic treatment.

Different problems require different approaches.

The presence of a hormone-related symptom does not automatically mean every hormone needs to be replaced.

2. What Does Your Medical History Tell Us?

Your medical history can substantially change the balance between potential benefit and potential risk.

Depending on the hormone being considered, physicians may need to review:

• Cardiovascular disease

• Previous heart attack or stroke

• Blood-clotting history

• Breast or other hormone-sensitive cancers

• Prostate health

• Liver disease

• Blood pressure

• Hematocrit

• Sleep apnea

• Abnormal vaginal bleeding

• Migraine history

• Current medications

• Family medical history

Two patients with similar symptoms may therefore receive different recommendations because their underlying risk profiles are different.

3. What Role Should Laboratory Testing Play?

Laboratory testing is important, but its role differs considerably depending on the situation.

In men being evaluated for testosterone deficiency, appropriate testosterone testing is central to diagnosis.

Menopausal hormone therapy is different. A woman with a typical clinical history of menopause does not necessarily need a hormone panel to "prove" that she is menopausal before treatment decisions can be discussed.

Laboratory testing may instead be useful for evaluating alternative causes of symptoms, establishing important baseline information, or monitoring specific treatments.

The most useful approach is therefore not simply ordering as many hormone tests as possible.

It is determining which information will actually change the clinical decision.

4. Which Hormone and Delivery Method Make the Most Sense?

Route of administration can matter.

Estrogen, for example, can be administered orally or through transdermal preparations such as patches and gels. These routes do not have identical effects on the body.

Testosterone may be delivered through injections, gels, patches, pellets, or other formulations depending on the clinical situation.

The choice may depend on:

• Medical risk factors

• Desired dosing flexibility

• Convenience

• Cost

• Medication availability

• Adherence

• Side-effect profile

• Patient preference

• How easily the treatment can be adjusted

There is no single form of HRT that is universally best.

The best option is the one that appropriately balances effectiveness, safety, practicality, and adjustability for the individual patient.

5. What Are Your Fertility and Reproductive Goals?

This is particularly important before testosterone therapy.

External testosterone can suppress the hormonal signals that stimulate sperm production and may significantly reduce fertility.

Men who are currently trying to conceive—or who may want biological children in the future—should discuss fertility before beginning testosterone therapy. The Endocrine Society specifically recommends against initiating testosterone therapy in men planning fertility in the near term.

Reproductive considerations may also influence hormone treatment decisions in women depending on age, menstrual status, pregnancy potential, and the reason therapy is being considered.

6. What Matters Most to You?

Medical decision-making is not based exclusively on laboratory numbers.

Patients may place different values on:

• Symptom relief

• Sexual function

• Sleep

• Convenience

• Avoiding injections

• Avoiding daily medication

• Medication cost

• Treatment flexibility

• Fertility

• Long-term health considerations

One patient may prefer the flexibility of a treatment that can be stopped or changed quickly.

Another may prioritize convenience and less frequent dosing.

When several medically reasonable options exist, patient preference is an important part of shared decision-making.

7. How Will Treatment Be Monitored?

Starting hormone therapy should never be the end of the evaluation.

The treatment plan should include a strategy for follow-up.

Depending on the therapy, monitoring may include:

• Symptom response

• Side effects

• Blood pressure

• Hormone levels when clinically appropriate

• Hemoglobin and hematocrit

• Prostate monitoring when appropriate

• Breast or gynecologic symptoms

• Unexpected vaginal bleeding

• Sexual health

• Fertility considerations

• Medication adherence

• Changes in medical history

• Whether the treatment is still needed

Testosterone products can increase hematocrit and may increase blood pressure, making appropriate follow-up particularly important. FDA labeling requirements for testosterone products have also continued to evolve as cardiovascular and blood-pressure safety data have accumulated.

For practical information about beginning treatment, see A Patient’s Guide to Starting Hormone Replacement Therapy.

Who May Need Additional Caution With Hormone Therapy?

Certain medical conditions can make hormone therapy inappropriate or require additional evaluation, specialist involvement, or a different treatment approach.

For menopausal hormone therapy, important considerations may include:

• Certain hormone-sensitive cancers

• Unexplained vaginal bleeding

• Previous blood clots

• Previous stroke or heart attack

• Significant liver disease

• Certain cardiovascular risks

• Other individual contraindications to the medication being considered

For testosterone therapy in men, important considerations may include:

• Current fertility goals

• Known or suspected prostate or breast cancer

• Elevated hematocrit

• Severe untreated obstructive sleep apnea

• Certain severe urinary symptoms

• Uncontrolled heart failure

• Recent myocardial infarction or stroke

• Thrombophilia or significant blood-clotting risk

These are not situations that should be assessed from a checklist alone.

The specific hormone, route, dose, severity of the underlying condition, and complete medical picture all matter.

Potential Benefits Must Be Weighed Against Potential Risks

Hormone therapy can provide meaningful benefits when the treatment matches the clinical problem.

Menopausal hormone therapy can be highly effective for vasomotor symptoms and certain genitourinary symptoms and can help prevent bone loss in appropriately selected women.

Testosterone replacement can improve manifestations of testosterone deficiency in appropriately diagnosed men.

But no medication is free of risk.

Potential concerns vary according to the hormone and may include:

• Blood clots

• Changes in hematocrit

• Blood-pressure changes

• Breast or uterine considerations

• Prostate monitoring considerations

• Acne or skin changes

• Fluid retention

• Changes in lipid levels

• Abnormal bleeding

• Fertility effects

• Medication-specific side effects

Importantly, these risks are not identical for every patient or every formulation.

Age, dose, route, timing, underlying disease, and duration of therapy can all influence the risk-benefit calculation.

For a deeper discussion, see The Benefits and Risks of HRT: What Current Research Shows.

Does "Bioidentical" Mean a Hormone Is Better for You?

Not necessarily.

The term bioidentical generally refers to a hormone with a molecular structure identical to a hormone produced naturally by the human body.

It does not automatically mean that the product is safer, more effective, more individualized, or compounded.

FDA-approved estradiol and micronized progesterone products are examples of medications that may be described as bioidentical.

Compounded hormones can be useful in selected circumstances when a commercially available medication cannot meet a legitimate clinical need, but they do not undergo the same FDA premarket evaluation as approved medications.

Hormone therapy should therefore be selected according to medical evidence, patient needs, formulation, dose, route, and safety considerations—not simply because a product is marketed as "natural" or "bioidentical."

Read more in Bioidentical Hormones vs Traditional Hormone Therapy.

HRT Should Not Be a "Set It and Forget It" Treatment

Your health is not static.

Neither should your hormone treatment be.

Over time:

• Symptoms may improve

• New medical conditions may develop

• Medications may change

• Treatment goals may change

• Risk factors may change

• Laboratory findings may change

• A different dose or formulation may become more appropriate

• Hormone therapy may no longer be necessary

This is why ongoing reassessment matters.

There is also no universal rule stating that every patient must stop hormone therapy after a predetermined number of years. The appropriate duration depends on the therapy, symptoms being treated, treatment response, evolving health risks, patient preference, and continued benefit.

The goal is not to keep someone on HRT indefinitely simply because treatment was once started.

The goal is to periodically ask:

Is this treatment still helping, is it still appropriate, and does the benefit continue to justify the risk?

Questions to Ask Before Starting Hormone Therapy

Before beginning treatment, it can be helpful to discuss questions such as:

• What symptoms or condition are we actually treating?

• How confident are we that hormones are contributing to my symptoms?

• Are there other medical causes we should evaluate?

• Do I need laboratory testing?

• What are the realistic benefits of treatment?

• What risks are most relevant to my personal health history?

• Which hormone formulation and delivery method would you recommend?

• Why are you recommending that particular option?

• What side effects should I watch for?

• How will treatment be monitored?

• When will we reassess whether it is working?

• Could treatment affect fertility?

• What alternatives are available if I choose not to use hormone therapy?

Good hormone care should leave you understanding not only what is being prescribed, but why.

So, Is HRT Right for You?

Hormone therapy may be worth discussing when you have symptoms or a diagnosed condition for which hormone treatment has a reasonable clinical rationale and the anticipated benefits outweigh the potential risks.

It should not be recommended solely because:

• You reached a certain age

• You feel tired

• You gained weight

• A single hormone level was outside a preferred range

• An online symptom quiz suggested "hormone imbalance"

• A treatment program promises to "optimize" every hormone

• Someone else felt better using the same treatment

The strongest hormone therapy decisions combine:

Your symptoms + your medical history + appropriate testing + your health risks + your goals + your preferences + ongoing monitoring.

That is individualized hormone care.

For a shorter overview specifically focused on eligibility, read Am I a Candidate for Hormone Replacement Therapy?.

Personalized Hormone Replacement Therapy in Arizona

At Ask Dr. Hu, hormone therapy begins with an individualized medical evaluation rather than a predetermined treatment protocol.

We review symptoms, medical history, medications, relevant laboratory findings, risk factors, reproductive considerations, and personal treatment goals before determining whether hormone therapy may be appropriate.

When treatment is recommended, the medication, dose, delivery method, and monitoring strategy are selected according to the individual patient and adjusted when clinically appropriate.

Learn more about Hormone Replacement Therapy for women and men in Arizona, or explore our complete Hormone Replacement Therapy Resource Center.

Evidence-Based Medical References

This article is intended to provide evidence-informed patient education. Hormone replacement therapy recommendations differ according to the hormone being considered, the condition being treated, and the individual patient's medical history.

Authoritative sources used in developing and reviewing this article include:

• The Menopause Society – Hormone Therapy Position Statements, including guidance emphasizing individualized assessment of menopausal hormone therapy.

• The Endocrine Society – Testosterone Therapy for Hypogonadism Clinical Practice Guideline, including recommendations regarding diagnosis, appropriate patient selection, contraindications, fertility considerations, and monitoring.

• The Endocrine Society – 2026 Statement on Testosterone Replacement Therapy, addressing current evidence surrounding diagnosis, testing quality, benefits, risks, and appropriate monitoring.

• U.S. Food and Drug Administration – Testosterone Product Safety and Labeling, including updated cardiovascular and blood-pressure labeling information.

• U.S. Food and Drug Administration – Menopausal Hormone Therapy Labeling Information, reflecting evolving benefit-risk considerations for menopausal hormone therapy.

Medical recommendations and medication labeling can change as new evidence becomes available. Individual treatment decisions should be made with a qualified healthcare professional familiar with the patient's complete medical history.

About the Author

YiQiu Hu, NMD

Dr. YiQiu Hu is an Arizona-licensed naturopathic physician and founder of Ask Dr. Hu. His clinical work includes concierge medicine, preventive healthcare, health optimization, laboratory evaluation, medical weight management, hormone care, integrative pain management, and individualized treatment planning.

At Ask Dr. Hu, Dr. Hu provides personalized medical care for patients throughout Arizona with an emphasis on thorough evaluation, clear explanations, evidence-informed treatment options, and ongoing physician-patient relationships.

This article is provided for general educational purposes and does not replace individualized medical evaluation, diagnosis, or treatment.